Close
  Indian J Med Microbiol
 

Figure 1: Morphology of breast cancer cell line (MCF-7) for (a) control; (b and c) paclitaxel and hyaluronic acid-paclitaxel treated at 1 ng/ml; (d and e) paclitaxel and hyaluronic acid-paclitaxel treated at 100 ng/ml; colorectal cancer cell line (HT-29) for (f) control; (g and h) paclitaxel and hyaluronic acid-paclitaxel treated at 1 ng/ml; (i and j) paclitaxel and hyaluronic acid-paclitaxel treated at 100 ng/ml after 24 h

Figure 1: Morphology of breast cancer cell line (MCF-7) for (a) control; (b and c) paclitaxel and hyaluronic acid-paclitaxel treated at 1 ng/ml; (d and e) paclitaxel and hyaluronic acid-paclitaxel treated at 100 ng/ml; colorectal cancer cell line (HT-29) for (f) control; (g and h) paclitaxel and hyaluronic acid-paclitaxel treated at 1 ng/ml; (i and j) paclitaxel and hyaluronic acid-paclitaxel treated at 100 ng/ml after 24 h